Spirobarbital
Chemical compound
- none
- 1-ethyl-2,4-dimethyl-7,9-diazaspiro[4.5]decane-6,8,10-trione
- 72035-36-0 Y
- Sodium salt: 12262-77-0 Y
- LR477QH2IL
- Sodium salt: 4NGD254IO1 Y
- DTXSID601027534
- Interactive image
- O=C2NC(=O)NC(=O)C12C(CC)C(C)CC1C
Spirobarbital is a barbiturate derivative developed by Eli Lilly in the 1940s.[1] It has hypnotic and sedative effects, and has a moderate potential for abuse.[2]
References
- v
- t
- e
Hypnotics/sedatives (N05C)
Alcohols |
|
---|---|
Barbiturates |
|
Benzodiazepines | |
Carbamates | |
Imidazoles | |
Monoureides |
|
Neuroactive steroids | |
Nonbenzodiazepines | |
Phenols | |
Piperidinediones | |
Quinazolinones | |
Others |
Antihistamines | |
---|---|
Antidepressants | |
Antipsychotics |
Antidepressants | |
---|---|
Antipsychotics | |
Others |
- Agomelatine
- Melatonin
- Ramelteon
- Tasimelteon
- Cannabidiol
- Cannabis
- Chlorophenylalkyldiols
- Diethylpropanediol
- Evoxine
- Fenadiazole
- Guaifenesin-related muscle relaxants
- Midaflur
- Opioids (e.g., morphine)
- Passion flower
- Scopolamine
- Trazodone
- UMB68
- Valnoctamide
This sedative-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e